Search research articles
Contact Us
Filters
Showing results (91-100 of 122) with videos related to
Page
of 13
Sort By:
European Journal of Human Genetics : EJHG
|
March 13, 2015
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
Intza Garin, Giovanna Mantovani, Urko Aguirre, et al.
JCO Precision Oncology
|
March 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 17, 2015
Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms
Intza Garin, Francesca M Elli, Agnes Linglart, et al.
British Journal of Haematology
|
May 21, 2019
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)
Elena M Elli, Alessandra Iurlo, Andrea Aroldi, et al.
Leukemia
|
May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea
Francesca Palandri, Massimo Breccia, Elena M Elli, et al.
Journal of Endocrinological Investigation
|
February 7, 2023
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis
D-A Ertl, G Mantovani, G P de Nanclares, et al.
Clinical and Experimental Medicine
|
January 20, 2024
Idiopathic erythrocytosis: a germline disease?
E M Elli, M Mauri, D D'Aliberti, et al.
European Journal of Endocrinology
|
July 13, 2016
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network
Susanne Thiele, Giovanna Mantovani, Anne Barlier, et al.
Cancer Medicine
|
January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Annals of Hematology
|
March 13, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective study
F Palandri, G Auteri, E Abruzzese, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 122) with videos related to
Sort By:
Page
of 13
European Journal of Human Genetics : EJHG
|
March 13, 2015
European guidance for the molecular diagnosis of pseudohypoparathyroidism not caused by point genetic variants at GNAS: an EQA study
Intza Garin, Giovanna Mantovani, Urko Aguirre, et al.
JCO Precision Oncology
|
March 14, 2024
Investigation of Serum Albumin as a Dynamic Treatment-Specific Surrogate for Outcomes in Patients With Myelofibrosis Treated With Ruxolitinib
Andrew T Kuykendall, Somedeb Ball, Barbara Mora, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 17, 2015
Novel microdeletions affecting the GNAS locus in pseudohypoparathyroidism: characterization of the underlying mechanisms
Intza Garin, Francesca M Elli, Agnes Linglart, et al.
British Journal of Haematology
|
May 21, 2019
Deferasirox in the management of iron-overload in patients with myelofibrosis: a multicentre study from the Rete Ematologica Lombarda (IRON-M study)
Elena M Elli, Alessandra Iurlo, Andrea Aroldi, et al.
Leukemia
|
May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyurea
Francesca Palandri, Massimo Breccia, Elena M Elli, et al.
Journal of Endocrinological Investigation
|
February 7, 2023
Growth patterns and outcomes of growth hormone therapy in patients with acrodysostosis
D-A Ertl, G Mantovani, G P de Nanclares, et al.
Clinical and Experimental Medicine
|
January 20, 2024
Idiopathic erythrocytosis: a germline disease?
E M Elli, M Mauri, D D'Aliberti, et al.
European Journal of Endocrinology
|
July 13, 2016
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network
Susanne Thiele, Giovanna Mantovani, Anne Barlier, et al.
Cancer Medicine
|
January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Annals of Hematology
|
March 13, 2024
Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the "RAMP" Italian multicenter prospective study
F Palandri, G Auteri, E Abruzzese, et al.
Page
of 13